-+ 0.00%
-+ 0.00%
-+ 0.00%

Veru Secures US Patent for Enobosarm With Semaglutide Through Late 2044

PUBT·11/17/2026 13:31:59
Listen to the news
Veru Secures US Patent for Enobosarm With Semaglutide Through Late 2044
  • Veru received a US patent covering enobosarm with semaglutide, with protection extending until late 2044.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veru Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611170830PRIMZONEFULLFEED9878723) on November 17, 2026, and is solely responsible for the information contained therein.